Translate

Thursday, August 15, 2019

MDM2 counteracts resistance to CDK4/6 inhibitors for melanoma therapy

A study has identified a possible second-line treatment for melanoma patients.

from Breast Cancer News -- ScienceDaily https://ift.tt/2KM8AQt
Posted by HodgePodge at 3:20 PM
Labels: ,

0 comments:

Post a Comment

Subscribe to: Post Comments (Atom)